SUBCUTANEOUS IMMUNOGLOBULIN IgPro20 (HIZENTRA) IN PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIPD) IN ITALY: A BUDGET IMPACT MODEL

被引：0
|
作者：
Cocito, D. [1 ]
Pinter, Lauria G. [2 ,3 ]
Boggia, G. [4 ]
Mangia, P. [5 ]
Villa, S. [5 ]
Cicchetti, A. [6 ]
机构：
[1] Univ Turin, Dept Neurosci, Turin, Italy
[2] IRCCS Fdn Carlo Besta Neurol Inst, Neurol Unit 3, Milan, Italy
[3] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Milan, Italy
[4] CSL Behring, Med Affairs, Milan, Italy
[5] CSL Behring, Market Access, Milan, Italy
[6] Postgrad Sch Hlth Econ ALTEMS, Rome, Italy
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2019年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [1] A Budget Impact Model of Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with IgPro20 (Hizentra) Relative to Intravenous Immunoglobulin in the United States
    Rajiv Mallick
    Rashad Carlton
    Joris Van Stiphout
    PharmacoEconomics - Open, 2023, 7 : 243 - 255
  • [2] A Budget Impact Model of Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with IgPro20 (Hizentra) Relative to Intravenous Immunoglobulin in the United States
    Mallick, Rajiv
    Carlton, Rashad
    Van Stiphout, Joris
    PHARMACOECONOMICS-OPEN, 2023, 7 (02) : 243 - 255
  • [3] IgPro20, the Polyneuropathy and Treatment with Hizentra® study (PATH), and the treatment of chronic inflammatory demyelinating polyradiculoneuropathy with subcutaneous IgG
    Berger, Melvin
    Harbo, Thomas
    Cornblath, David R.
    Mielke, Orell
    IMMUNOTHERAPY, 2018, 10 (11) : 919 - 933
  • [4] SUBCUTANEOUS IMMUNOGLOBULIN (IGPRO20) DOSE ADJUSTMENTS FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MAINTENANCE THERAPY IN CLINICAL PRACTICE
    Pulley, Michael
    Sharma, Khema
    Vu, Tuan
    Jiang, Nan
    Peltier, Amanda
    Khella, Sami
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S115 - S115
  • [5] INFUSION PARAMETERS FOR SUBCUTANEOUS IMMUNOGLOBULIN (IGPRO20) IN THE MAINTENANCE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: THE PATH TRIAL
    Dacci, P.
    van Schaik, I
    Bril, V
    van Geloven, N.
    Hartung, H.
    Lewis, R.
    Sobue, G.
    Lawo, J.
    Mieke, O.
    Durn, B.
    Cornblath, D.
    Merkies, I
    Dimachkie, M.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2019, 24 : S16 - S17
  • [6] MAINTENANCE TREATMENT FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIPD) WITH SUBCUTANEOUS IMMUNOGLOBULIN IGPRO20: THE MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PATH TRIAL
    Pinter, Lauria G.
    van Schaik, I
    Bril, V
    van Geloven, N.
    Hartung, H.
    Lewis, R.
    Sobue, G.
    Lawo, J.
    Mieke, O.
    Durn, B.
    Cornblath, D.
    Merkies, I
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2019, 24 : S26 - S26
  • [7] REAL-WORLD SAFETY ASSESSMENT OF TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY WITH SUBCUTANEOUS IGPRO20
    Divino, Victoria
    Mallick, Rajiv
    Lahue, Betsy
    Coyle, Katharine
    Wang, Yi
    DeKoven, Mitch
    Hubsch, Alphonse
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S106 - S106
  • [8] REAL-WORLD SAFETY AND TREATMENT PATTERN OF IGPRO20 IN JAPANESE PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
    Terasaka, Naoki
    Mizushima, Takanori
    Niwa, Yuki
    Doi, Mamoru
    Akasaki, Tetsushi
    Usui, Hideo
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S152 - S153
  • [9] CORRELATION BETWEEN SERUM IgG LEVELS AND FUNCTIONAL OUTCOMES IN THE PATH TRIAL OF SUBCUTANEOUS IMMUNOGLOBULIN IgPro20 MAINTENANCE THERAPY IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
    Cocito, D.
    Cornblath, D.
    Lewis, R.
    Bril, V
    van Geloven, N.
    Hartung, H.
    Sobue, G.
    Tortorici, M.
    Mieke, O.
    Lawo, J.
    Durn, B.
    Merkies, I
    van Schaik, I
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2019, 24 : S13 - S14
  • [10] Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) study
    Bril, Vera
    Hartung, Hans-Peter
    Lawo, John-Philip
    Durn, Billie L.
    Mielke, Orell
    CLINICAL NEUROPHYSIOLOGY, 2021, 132 (01) : 226 - 231
12345